Biotech | December 15, 2021
Aragen Life Sciences acquires Intox
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
FDA changes inspection classification of the facility to Voluntary Action Indicated
The company will manufacture a cancer immunotherapy product from 2022
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
An MoU was signed between B Medical Systems and Gujarat government recently
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The week-long campaign received a record 17.691 pledges
Subscribe To Our Newsletter & Stay Updated
